Results 91 to 100 of about 36,320 (224)
In response to various neurohumoral substances endothelial cells release nitric oxide (NO), prostacyclin and produce hyperpolarization of the underlying vascular smooth muscle cells by a yet unknown mechanism attributed to an endothelium-derived ...
Félétou, M, Vanhoutte, PM
core
Prostacyclin in liver disease: a potential therapeutic option.
Complex molecular and cellular mechanismsare involved in t progression of hepatic fibrosis. Recent studies have show stellate cells, endothelin, cytokines and prostacyclin play cru pathology.
ZARDI EM +3 more
core +1 more source
Comparative effects of nitroglycerin and nitroprusside on prostacyclin generation in adult human vessel wall [PDF]
The precise mechanism of vasodilatory actions of nitroso-compounds is not clear. It has been suggested that these drugs might modulate release of the vasodilator, prostacyclin, from cultured endothelial cells and bovine arteries or potentiate actions of ...
Faro, Richard +5 more
core +1 more source
BCP crystals increase prostacyclin production and upregulate the prostacyclin receptor in OA synovial fibroblasts: potential effects on mPGES1 and MMP-13 [PDF]
SummaryObjectiveTo investigate the potential involvement of prostacyclin in basic calcium phosphate (BCP) crystal-induced responses in osteoarthritic synovial fibroblasts (OASF).MethodsOASF grown in culture were stimulated with BCP crystals. Prostacyclin
McCarthy, G.M. +4 more
core +1 more source
Double-blind controlled trial of prostacyclin in cerebral infarction.
Thirty-two patients with acute cerebral infarction received either prostacyclin or placebo intermittently for 65 hours. Pulse and blood pressure were not altered by prostacyclin. After infusion there was no change in infarct volume or cerebral blood flow
N Lewtas +7 more
core +1 more source
Long‐term intravenous (IV) epoprostenol is a key therapy for pulmonary arterial hypertension (PAH); however, rare immune‐mediated conditions occurring during therapy remain incompletely characterised.
Takashi Inao +9 more
doaj +1 more source
PHARMACOLOGICAL PROPERTIES OF MM-706, A NEW PROSTACYCLIN DERIVATIVE
. 1. In human platelet-rich plasma, platelet aggregation induced in vitro by collagen (10 μg/ml) or thrombin (50 mU/ml) was dose-dependently inhibited by increasing concentrations of prostacyclin or of the new derivative (±)(5E)-13,14-didehydro-ω ...
LILLE U +5 more
core +1 more source
Role of phosphoinositides in the regulation of endothelial prostacyclin production.
To elucidate the role of the phosphoinositide signal transduction system in endothelial endothelial prostacyclin production, endothelial cells from human umbilical veins previously labelled with 3H-inositol were incubated with thrombin or histamine ...
H Halldórsson, M Kjeld, G Thorgeirsson
core +1 more source
DDAVP stimulates prostacyclin production
Des-amino-D-arginine vasopressin (DDAVP) stimulates the release of factor VIII and plasminogen activator from the vascular endothelium. An infusion of exogenous factor VIII given to haemophiliacs causes an increase in platelet activation. This activation
Lowe, G. D. +7 more
core +2 more sources

